EGFR and head and neck squamous cell carcinoma: Accumulating evidence indicates that besides EGFR activation, the mesenchymal-to-epithelial transition factor (c-Met) and its ligand, hepatocyte growth factor (HGF), are also aberrantly activated in HNSCC.